Literature DB >> 33411781

First approach to the population structure of Mycobacterium tuberculosis complex in the indigenous population in Puerto Nariño-Amazonas, Colombia.

Alejandro Vega Marín1, Nalin Rastogi2, David Couvin2, Viviana Mape1, Martha Isabel Murcia1.   

Abstract

INTRODUCTION: Tuberculosis affects vulnerable groups to a greater degree, indigenous population among them.
OBJECTIVE: To determine molecular epidemiology of clinical isolates of Mycobacterium tuberculosis circulating in an indigenous population through Spoligotyping and 24-loci MIRU-VNTR.
METHODOLOGY: A descriptive cross-sectional study was conducted in 23 indigenous communities of Puerto Nariño-Amazonas, Colombia. Recovered clinical isolates were genotyped. For genotyping analyzes global SITVIT2 database and the MIRU-VNTRplus web portal were used.
RESULTS: 74 clinical isolates were recovered. Genotyping of clinical isolates by spoligotyping determined 5 different genotypes, all of them belonged to Euro-American lineage. By MIRU-VNTR typing, a total of 14 different genotypes were recorded. Furthermore, polyclonal infection was found in two patients from the same community. The combination of the two methodologies determined the presence of 19 genotypes, 8 formed clusters with 63 clinical isolates in total. Based on epidemiological information, it was possible to establish a potential chain of active transmission in 10/63 (15.9%) patients.
CONCLUSIONS: High genomic homogeneity was determined in the indigenous population suggesting possible chains of active transmission. The results obtained showed that specific genotypes circulating among the indigenous population of Colombia are significantly different from those found in the general population.

Entities:  

Mesh:

Year:  2021        PMID: 33411781      PMCID: PMC7790298          DOI: 10.1371/journal.pone.0245084

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  40 in total

Review 1.  Indigenous health in Latin America and the Caribbean.

Authors:  Raul A Montenegro; Carolyn Stephens
Journal:  Lancet       Date:  2006-06-03       Impact factor: 79.321

2.  Methods of quantifying and visualising outbreaks of tuberculosis using genotypic information.

Authors:  Mark M Tanaka; Andrew R Francis
Journal:  Infect Genet Evol       Date:  2005-01       Impact factor: 3.342

3.  spolTools: online utilities for analyzing spoligotypes of the Mycobacterium tuberculosis complex.

Authors:  Chaka Tang; Josephine F Reyes; Fabio Luciani; Andrew R Francis; Mark M Tanaka
Journal:  Bioinformatics       Date:  2008-08-18       Impact factor: 6.937

4.  Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates.

Authors:  Caroline Allix-Béguec; Dag Harmsen; Thomas Weniger; Philip Supply; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

Review 5.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

6.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Proportion of tuberculosis transmission that takes place in households in a high-incidence area.

Authors:  Suzanne Verver; Robin M Warren; Zahn Munch; Madalene Richardson; Gian D van der Spuy; Martien W Borgdorff; Marcel A Behr; Nulda Beyers; Paul D van Helden
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

8.  Macro-geographical specificities of the prevailing tuberculosis epidemic as seen through SITVIT2, an updated version of the Mycobacterium tuberculosis genotyping database.

Authors:  David Couvin; Audrey David; Thierry Zozio; Nalin Rastogi
Journal:  Infect Genet Evol       Date:  2018-12-26       Impact factor: 3.342

Review 9.  Co-evolution of Mycobacterium tuberculosis and Homo sapiens.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

10.  Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.

Authors:  Timothy M Walker; Camilla L C Ip; Ruth H Harrell; Jason T Evans; Georgia Kapatai; Martin J Dedicoat; David W Eyre; Daniel J Wilson; Peter M Hawkey; Derrick W Crook; Julian Parkhill; David Harris; A Sarah Walker; Rory Bowden; Philip Monk; E Grace Smith; Tim E A Peto
Journal:  Lancet Infect Dis       Date:  2012-11-15       Impact factor: 25.071

View more
  3 in total

1.  CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis.

Authors:  Shuqi Li; Nicholas C Poulton; Jesseon S Chang; Zachary A Azadian; Michael A DeJesus; Nadine Ruecker; Matthew D Zimmerman; Kathryn A Eckartt; Barbara Bosch; Curtis A Engelhart; Daniel F Sullivan; Martin Gengenbacher; Véronique A Dartois; Dirk Schnappinger; Jeremy M Rock
Journal:  Nat Microbiol       Date:  2022-05-30       Impact factor: 30.964

2.  Consistency of Mycobacterium tuberculosis Complex Spoligotyping between the Membrane-Based Method and In Silico Approach.

Authors:  Charlotte Genestet; Elisabeth Hodille; Albin Bernard; Maxime Vallée; Gérard Lina; Adrien Le Meur; Guislaine Refrégier; Oana Dumitrescua
Journal:  Microbiol Spectr       Date:  2022-04-25

3.  Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory.

Authors:  Charlotte Genestet; Yannick Baffert; Maxime Vallée; Albin Bernard; Yvonne Benito; Gérard Lina; Elisabeth Hodille; Oana Dumitrescu
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.